How to raise venture capital for an InsurTech startup in 2026.
InsurTech — Lemonade, Next Insurance, Hippo, Coalition, At-Bay, Vouch, Kin, Openly, Newfront, Ethos — spans personal lines, commercial P&C, cyber, life, embedded, and broker-tech. It has its own investor set and diligence norms around MGA vs full-stack tradeoffs, reinsurance capacity, loss ratios, and state-by-state regulatory approvals.
Insurance combines software, distribution, and balance-sheet risk. Whether the company is an MGA (managing general agent — writing on a carrier's paper) or full-stack carrier changes valuation, capital needs, and diligence. Loss ratios, combined ratios, and reinsurance treaty quality drive underwriting math.
InsurTech specialists: MTech Capital, Anthemis, MassMutual Ventures, IA Capital, Eos Venture Partners, Munich Re Ventures, Nationwide Ventures, American Family Ventures, State Farm Ventures, and Guidewire Insurance Platform.
Multi-stage active in InsurTech: Ribbit Capital, QED, Founders Fund, Andreessen Horowitz, Index, Bessemer, Lightspeed, and General Catalyst.
Reinsurance capacity partners: Munich Re, Swiss Re, Hannover Re, SCOR, Everest Re, RenaissanceRe, and Lloyd's syndicates. Capacity relationships often unlock or block growth.
MGA: fast to launch, capital-light, needs carrier paper + reinsurance capacity. Revenue = commission + profit-share. Lemonade started as an MGA before becoming a full-stack carrier.
Full-stack carrier: owns underwriting, requires state insurance department approvals (surplus lines vs admitted), holds statutory capital, and consolidates loss ratio directly. Higher potential valuation, materially more capital-intensive.
Loss ratio (losses / premium), expense ratio, and combined ratio (<100% = underwriting profit) drive InsurTech quality. Reinsurance quota-share treaties can smooth combined ratio and free capital, but poor pricing signals weak underwriting. Investors diligence loss triangles, PMLs (probable maximum losses), and cat exposure.
Confusing MGA revenue with carrier revenue. Not disclosing reinsurance dependence. Weak loss-triangle disclosure. Under-capitalizing statutory reserves for full-stack. Ignoring state-by-state licensing timelines.
Investor directory · Fundraising library · Articles A–Z · Company funding database